0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Natural Killer (NK) Cell Therapeutics Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-5C13853
Home | Market Reports | Health| Health Conditions| Cancer
Global Natural Killer NK Cell Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Natural Killer (NK) Cell Therapeutics Market Research Report 2024

Code: QYRE-Auto-5C13853
Report
April 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Natural Killer (NK) Cell Therapeutics Market Size

The global Natural Killer (NK) Cell Therapeutics market was valued at US$ 255.8 million in 2023 and is anticipated to reach US$ 324.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Natural Killer (NK) Cell Therapeutics Market

Natural Killer (NK) Cell Therapeutics Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Natural Killer (NK) Cell Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer (NK) Cell Therapeutics.

Report Scope

The Natural Killer (NK) Cell Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer (NK) Cell Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer (NK) Cell Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Natural Killer (NK) Cell Therapeutics Market Report

Report Metric Details
Report Name Natural Killer (NK) Cell Therapeutics Market
Accounted market size in 2023 US$ 255.8 million
Forecasted market size in 2030 US$ 324.8 million
CAGR 3.4%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Segment by Application
  • Cancer
  • Cardiovascular Diseases
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Natural Killer (NK) Cell Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Natural Killer (NK) Cell Therapeutics Market growing?

Ans: The Natural Killer (NK) Cell Therapeutics Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Natural Killer (NK) Cell Therapeutics Market size in 2030?

Ans: The Natural Killer (NK) Cell Therapeutics Market size in 2030 will be US$ 324.8 million.

What is the Natural Killer (NK) Cell Therapeutics Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the Natural Killer (NK) Cell Therapeutics Market share by application?

Ans: The cancer segment accounted for a major share in 2019 (66.99%).

What is the market share of major companies in Natural Killer (NK) Cell Therapeutics Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Who are the main players in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The main players in the Natural Killer (NK) Cell Therapeutics Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services

What are the Application segmentation covered in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The Applications covered in the Natural Killer (NK) Cell Therapeutics Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Natural Killer (NK) Cell Therapeutics Market report?

Ans: The Types covered in the Natural Killer (NK) Cell Therapeutics Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2019-2030)
2.2 Natural Killer (NK) Cell Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Natural Killer (NK) Cell Therapeutics Market Dynamics
2.3.1 Natural Killer (NK) Cell Therapeutics Industry Trends
2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers
2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges
2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2023
3.5 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2025-2030)
5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2019-2030)
6.2 North America Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024)
6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2019-2030)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024)
7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2019-2030)
9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Detail
11.1.2 Chipscreen Biosciences Business Overview
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction
11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.1.5 Chipscreen Biosciences Recent Development
11.2 Affimed NV
11.2.1 Affimed NV Company Detail
11.2.2 Affimed NV Business Overview
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction
11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.2.5 Affimed NV Recent Development
11.3 Altor BioScience
11.3.1 Altor BioScience Company Detail
11.3.2 Altor BioScience Business Overview
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction
11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.3.5 Altor BioScience Recent Development
11.4 Innate Pharma
11.4.1 Innate Pharma Company Detail
11.4.2 Innate Pharma Business Overview
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction
11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.4.5 Innate Pharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction
11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.5.5 Takeda Recent Development
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Detail
11.6.2 Sorrento Therapeutics Business Overview
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction
11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.6.5 Sorrento Therapeutics Recent Development
11.7 NantKwest
11.7.1 NantKwest Company Detail
11.7.2 NantKwest Business Overview
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction
11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.7.5 NantKwest Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 NKT
11.9.1 NKT Company Detail
11.9.2 NKT Business Overview
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction
11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.9.5 NKT Recent Development
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Detail
11.10.2 Henry Ford Health Services Business Overview
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction
11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
11.10.5 Henry Ford Health Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Mogamulizumab
    Table 3. Key Players of Lorvotuzumab Mertansine
    Table 4. Key Players of Others
    Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2019-2024)
    Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2025-2030)
    Table 11. Natural Killer (NK) Cell Therapeutics Market Trends
    Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers
    Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges
    Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints
    Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Natural Killer (NK) Cell Therapeutics Market Share by Players (2019-2024)
    Table 17. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2023)
    Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
    Table 22. Date of Enter into Natural Killer (NK) Cell Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2019-2024)
    Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2025-2030)
    Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2019-2024)
    Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2025-2030)
    Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Chipscreen Biosciences Company Detail
    Table 48. Chipscreen Biosciences Business Overview
    Table 49. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product
    Table 50. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 51. Chipscreen Biosciences Recent Development
    Table 52. Affimed NV Company Detail
    Table 53. Affimed NV Business Overview
    Table 54. Affimed NV Natural Killer (NK) Cell Therapeutics Product
    Table 55. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 56. Affimed NV Recent Development
    Table 57. Altor BioScience Company Detail
    Table 58. Altor BioScience Business Overview
    Table 59. Altor BioScience Natural Killer (NK) Cell Therapeutics Product
    Table 60. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 61. Altor BioScience Recent Development
    Table 62. Innate Pharma Company Detail
    Table 63. Innate Pharma Business Overview
    Table 64. Innate Pharma Natural Killer (NK) Cell Therapeutics Product
    Table 65. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 66. Innate Pharma Recent Development
    Table 67. Takeda Company Detail
    Table 68. Takeda Business Overview
    Table 69. Takeda Natural Killer (NK) Cell Therapeutics Product
    Table 70. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. Takeda Recent Development
    Table 72. Sorrento Therapeutics Company Detail
    Table 73. Sorrento Therapeutics Business Overview
    Table 74. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product
    Table 75. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 76. Sorrento Therapeutics Recent Development
    Table 77. NantKwest Company Detail
    Table 78. NantKwest Business Overview
    Table 79. NantKwest Natural Killer (NK) Cell Therapeutics Product
    Table 80. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 81. NantKwest Recent Development
    Table 82. Bristol-Myers Squibb Company Detail
    Table 83. Bristol-Myers Squibb Business Overview
    Table 84. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product
    Table 85. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. NKT Company Detail
    Table 88. NKT Business Overview
    Table 89. NKT Natural Killer (NK) Cell Therapeutics Product
    Table 90. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 91. NKT Recent Development
    Table 92. Henry Ford Health Services Company Detail
    Table 93. Henry Ford Health Services Business Overview
    Table 94. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product
    Table 95. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2019-2024) & (US$ Million)
    Table 96. Henry Ford Health Services Recent Development
    Table 97. Research Programs/Design for This Report
    Table 98. Key Data Information from Secondary Sources
    Table 99. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Mogamulizumab Features
    Figure 4. Lorvotuzumab Mertansine Features
    Figure 5. Others Features
    Figure 6. Global Natural Killer (NK) Cell Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2023 VS 2030
    Figure 8. Cancer Case Studies
    Figure 9. Cardiovascular Diseases Case Studies
    Figure 10. Others Case Studies
    Figure 11. Natural Killer (NK) Cell Therapeutics Report Years Considered
    Figure 12. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Natural Killer (NK) Cell Therapeutics Market Share by Region: 2023 VS 2030
    Figure 15. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2023
    Figure 16. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2023
    Figure 18. North America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Natural Killer (NK) Cell Therapeutics Market Share by Country (2019-2030)
    Figure 24. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Region (2019-2030)
    Figure 32. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Natural Killer (NK) Cell Therapeutics Market Share by Country (2019-2030)
    Figure 40. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Country (2019-2030)
    Figure 44. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 47. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 48. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 49. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 50. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 51. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 52. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 54. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 55. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2019-2024)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Antineoplastic Agents Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23H9930
Mon Jul 08 00:00:00 UTC 2024

Add to Cart

Global Hodgkin's Lymphoma Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-16R1165
Mon Jul 08 00:00:00 UTC 2024

Add to Cart

Global Polycythemia Vera Treatment Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-0O15761
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Exosome Medical Technology Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14U12944
Tue Jun 18 00:00:00 UTC 2024

Add to Cart